Stroke risk in elderly treated with antipsychotics is newly linked to specific drug actions

Reports new study in Biological Psychiatry

2013-03-11

(Press-News.org) Philadelphia, PA, March 11, 2013 – Antipsychotic administration in the elderly is associated with an increased risk for cerebrovascular accident, more commonly known as stroke; a new study published in Biological Psychiatry provides additional insight into this important relationship.

Antipsychotics are prescribed to elderly patients to treat symptoms such as agitation, psychosis, anxiety, insomnia, and depression. The increased risk of stroke associated with these medications was identified approximately a decade ago and has since been replicated by subsequent studies. Although the increase in stroke risk is small, some guidelines discourage the prescription of antipsychotics to elderly patients.

Antipsychotic drugs vary in their effects on the body and so it is likely that antipsychotics are not uniform in their effects on stroke risk. Thus, better understanding of the mechanisms through which antipsychotics increase stroke risk might guide the prescription of safer drugs for elderly patients.

In their study, Wu and colleagues focused on the wide range of brain mechanisms targeted by antipsychotic medications. All antipsychotics block the D2 subtype of receptor for the neurotransmitter dopamine. However, these drugs also act on a range of other receptor targets including the serotonin 5-HT2 receptor, the M1 receptor for the transmitter acetylcholine, and the alpha2 receptor for noradrenaline.

To conduct the study, the researchers matched information from a large national database of insurance claims to what is known about the receptor binding profiles of the antipsychotic drugs.

"We found that antipsychotics with a high binding affinity of alpha2 adrenergic and M1 muscarinic receptors were associated with a greater risk of stroke than the use of other types of antipsychotics," said Dr. Susan Shur-Fen Gau, Professor and Chair at National Taiwan University and corresponding author of the study.

They also found that this stroke risk was elevated in patients who were older and had dementia. Stroke risk was also related to duration and dosage of treatment, with patients who received either short duration of antipsychotic treatment (4 weeks or less) or higher daily doses of treatment showing an increased risk of stroke. This suggests that risk is highest in the initial weeks of antipsychotic treatment and for those with a higher average daily dose.

"Antipsychotics have a wide range of receptor profiles. The stroke risk profiles from this study suggest that it may be possible to use antipsychotics more safely in the elderly," commented Dr. John Krystal, Editor of Biological Psychiatry.

Additional research is necessary, but the authors agree. They recommend that clinicians start antipsychotics at low dosages and closely monitoring for side effects in the initial treatment, particularly for individuals with older age and the presence of dementia.

### The article is "Association of Stroke with the Receptor-Binding Profiles of Antipsychotics—A Case-Crossover Study" by Chi-Shin Wu, Sheng-Chang Wang, Susan Shur-Fen Gau, Hui-Ju Tsai, and Yu-Cheng Cheng (doi: 10.1016/j.biopsych.2012.07.006). The article appears in Biological Psychiatry, Volume 73, Issue 5 (March 1, 2013), published by Elsevier.

Notes for Editors Full text of the article is available to credentialed journalists upon request; contact Rhiannon Bugno at +1 214 648 0880 or Biol.Psych@utsouthwestern.edu. Journalists wishing to interview the authors may contact Susan Shur-Fen Gau at +886 2 23123456 ext 66802 or gaushufe@ntu.edu.tw.

The authors' affiliations, and disclosures of financial and conflicts of interests are available in the article.

John H. Krystal, M.D., is Chairman of the Department of Psychiatry at the Yale University School of Medicine and a research psychiatrist at the VA Connecticut Healthcare System. His disclosures of financial and conflicts of interests are available here.

About Biological Psychiatry Biological Psychiatry is the official journal of the Society of Biological Psychiatry, whose purpose is to promote excellence in scientific research and education in fields that investigate the nature, causes, mechanisms and treatments of disorders of thought, emotion, or behavior. In accord with this mission, this peer-reviewed, rapid-publication, international journal publishes both basic and clinical contributions from all disciplines and research areas relevant to the pathophysiology and treatment of major psychiatric disorders.

The journal publishes novel results of original research which represent an important new lead or significant impact on the field, particularly those addressing genetic and environmental risk factors, neural circuitry and neurochemistry, and important new therapeutic approaches. Reviews and commentaries that focus on topics of current research and interest are also encouraged.

Biological Psychiatry is one of the most selective and highly cited journals in the field of psychiatric neuroscience. It is ranked 5th out of 129 Psychiatry titles and 16th out of 243 Neurosciences titles in the Journal Citations Reports® published by Thomson Reuters. The 2011 Impact Factor score for Biological Psychiatry is 8.283.

ELSE PRESS RELEASES FROM THIS DATE:

Biodiesel algae: Starvation diets damage health

2013-03-11

It may be better to tolerate lower oil content in algae grown for biodiesel to boost growth and overall productivity, says research from the University of Sheffield. The research shows that the commonly accepted method of depriving algae of key nutrients such as nitrogen in order to boost its oil content may be detrimental to overall oil yield in the long term. "Total oil production depends not just on the oil content of the algal cells but how quickly the cells grow and multiply," says Dr Stephen Wilkinson of the University's Department of Chemical and Biological ...

Need for culturally sensitive treatment for deaf patients with psychiatric disorders

2013-03-11

Philadelphia, Pa. (March 11, 2013) – Members of the Deaf community who suffer from mental health problems need culturally sensitive treatment to avoid misdiagnosis and inappropriate treatment, according to a report in the March Journal of Psychiatric Practice. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health. "Deaf individuals comprise a cultural and linguistic minority group within the United States, and culturally and linguistically appropriate psychiatric treatment must reflect these differences," according to Sarah A. Landsberger, ...

Study finds fat and bone mass are genetically linked

2013-03-11

When it comes to body shape, diet and exercise can only take us so far. Our body shape and geometry are largely determined by genetic factors. Genetics also have an impact on our body composition – including soft fat tissue and hard bone tissue – and can lead to excess fat or osteoporosis. Now Prof. Gregory Livshits of Tel Aviv University's Department of Anatomy and Anthropology at the Sackler Faculty of Medicine, working alongside Dr. Michael Korostishevsky, has uncovered a clear genetic link between fat and bone mass. These factors, which contribute to bone metabolism, ...

Does winning an Emmy or an election mean you will live longer than those you beat?

2013-03-11

WASHINGTON, DC, March 11, 2013 — Research has long linked high socioeconomic status with better health and lower mortality. But what's remained unclear is whether this association has more to do with access to resources (education, wealth, career opportunity, etc.) or the glow of high social status relative to others. Scholars call the latter "relative deprivation." To tease apart these factors, a team of investigators at Columbia University's Mailman School of Public Health led by Dr. Bruce Link, studied Baseball Hall of Fame inductees, Emmy Award winners, and former ...

Researchers find alternative cholesterol-lowering drug for patients who can't tolerate statins

2013-03-11

SAN FRANCISCO — Heart patients who can't tolerate the side effects of cholesterol-lowering drugs may have a new option, according to a new study by researchers from the Intermountain Heart Institute at Intermountain Medical Center in Salt Lake City. Researchers found that pitavastatin, a newer cholesterol-lowering drug, may reduce the risk of heart attack, stroke and even death in up to 68 percent of patients with high cholesterol who can't tolerate other cholesterol-lowering medications due to side effects. Researchers are presenting the results of this study today ...

Glaciers contribute significant iron to North Atlantic Ocean

2013-03-11

All living organisms rely on iron as an essential nutrient. In the ocean, iron's abundance or scarcity means all the difference as it fuels the growth of plankton, the base of the ocean's food web. A new study by biogeochemists and glaciologists at Woods Hole Oceanographic Institution (WHOI) identifies a unexpectedly large source of iron to the North Atlantic – meltwater from glaciers and ice sheets, which may stimulate plankton growth during spring and summer. This source is likely to increase as melting of the Greenland ice sheet escalates under a warming climate. The ...

Antibiotic resistance 'has the potential to undermine modern health systems'

2013-03-11

Their warning comes as the Chief Medical Officer launches the UK's Antimicrobial Resistance Strategy and Action Plan, reflecting the need for a clear change in our understanding of and response to antimicrobial resistance by the public, NHS and government. Current estimates suggest that antibiotic resistance is a relatively cheap problem, they write, but such estimates do not take account of the fact that antimicrobial medicines are integral to modern healthcare. For example, antibiotics are given as standard to patients undergoing surgery, to women delivering by caesarean ...

New study explores link between status and health

2013-03-11

March 11, 2013 -- Research has long linked high socioeconomic status with better health and lower mortality. But what's remained unclear is whether this association has more to do with access to resources (education, wealth, career opportunity, etc.) or the glow of high social status relative to others. Scholars call the latter "relative deprivation." To tease apart these factors, a team of investigators at Columbia University's Mailman School of Public Health led by Dr. Bruce Link, studied Baseball Hall of Fame inductees, Emmy Award winners, and former Presidents and ...

New genetic study confirms Indian origins of pumpkins and cucumbers

2013-03-11

It had been suggested that the origin of pumpkins and cucumbers can be traced back to India. This has now been confirmed on the basis of genetic analyses performed by German and Indian botanists. The study was published in the open access journal PhytoKeys. Vegetables are essential components of a healthy daily diet, not just in India but around the globe. Compared to grains and pulses, however, vegetables are under-investigated taxonomically, and information on their genome is scarce. The cucumber family, Cucurbitaceae, includes many of our favorite foods: pumpkins, ...

Frustration may increase attraction to violent video games

2013-03-11

The temptation to steal or cheat is sometimes great — especially when the risk of being caught is low. A new study suggests that denying people the opportunity to engage in these taboo behaviors may lead them to seek out violent video games as a way of managing their frustration. The study, led by researcher Brad Bushman of Ohio State University, is published in Psychological Science, a journal of the Association for Psychological Science. Bushman and his colleagues want to understand what attracts people to violent media. In a previous study, they found that people ...

In a landmark study, an NYBG scientist and colleagues find that reforestation stands out among plant-based climate-mitigation strategies as most beneficial for wildlife biodiversity

Stroke risk in elderly treated with antipsychotics is newly linked to specific drug actions

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: